Fortive
Fortive Corporation (NYSE: FTV) designs, develops, manufactures, and markets technologies, software, and services for industrial, safety, and healthcare workflows. Its Intelligent Operating Solutions segment provides professional instruments for maintenance, repair, measurement, and condition monitoring, as well as… From the company’s description.
In fiscal 2025, Fortive reported revenue of $4.16B, down 33.3% from fiscal 2024, and net income of $532.70M. Its operating margin was 17.3%, and operations generated $1.08B in cash. Over the twelve months to Jul 3, 2026, revenue was $3.33B.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Fortive does
In the company’s own words
Fortive Corporation (NYSE: FTV) designs, develops, manufactures, and markets technologies, software, and services for industrial, safety, and healthcare workflows. Its Intelligent Operating Solutions segment provides professional instruments for maintenance, repair, measurement, and condition monitoring, as well as facility and asset lifecycle software and connected worker safety and compliance solutions. Customers and users include manufacturers, utilities, healthcare organizations, electricians, engineers, facility managers, and maintenance professionals. Brands include FLUKE, SERVICECHANNEL, GORDIAN, ACCRUENT, INDUSTRIAL SCIENTIFIC, and INTELEX. Its Advanced Healthcare Solutions segment supplies instrument sterilization and tracking, biomedical testing tools, radiation detection and safety monitoring, and clinical productivity software to healthcare providers. Its brands include ASP, CENSIS, FLUKE BIOMEDICAL, LANDAUER, and PROVATION. Fortive separated its Precision Technologies business into independent public company Ralliant in June 2025. In 2025, Fortive had more than 10,000 employees and operations in approximately 50 countries. Its website is www.fortive.com.
Company details
- Sector
- Industrials
- Industry (SIC)
- Medical Instruments
- Headquarters
- EVERETT, WA
- Fiscal year end
- December
- CIK
- 1659166
- SIC
- 3823
Financial performance, year by year
Fiscal 2016–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Fortive — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Superinvestors in Fortive · what they did last quarter
Share of each manager’s reported 13F portfolio. Change is in shares held, since the previous quarter.
Largest fund holders · Fortive’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fortive’s bonds, as funds hold them
Funds report holding 5 issues of Fortive’s debt, $175.25M at market value — what funds hold, not the company’s total debt. Weighted-average coupon 3.84%, maturing 2026 to 2046.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Fortive and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Fortive's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Fortive's last four quarterly filings that the numbers alone won't show?”